Court Issues Notice To Serum Institute Of India On Suit Against Use Of Name 'COVISHIELD' For Proposed Vaccine Share This - x A civil court in Maharashtra has issued notice to the Serum Institute of India(SII) in a passing off suit seeking to restrain the pharmaceutical company from using the trademark "COVISHIELD" or "COVID-SHIELD" or any other identical or similar name for its proposed vaccine for the Coronavirus induced pandemic.The civil suit was filed by a Nanded-based pharmaceutical company "Cutis Biotech"... Your free access to Live Law has expired To read the article, get a premium account. Your Subscription Supports Independent JournalismSubscription starts from